{
  "report_rows": [
    {
      "kpi": "Net Revenue (Q4 FY2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1,475M vs. cons $1,460M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Gross Margin (Q4 FY2026)",
      "prediction": "BEAT",
      "answer": "pred ~63.2% vs. cons ~62.7%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Diluted EPS (Q4 FY2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.97 vs. cons $2.89",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2027 Revenue (FY2027)",
      "prediction": "BETTER",
      "answer": "guide ~$5,950-6,050M vs. cons $5,942M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2027 Non-GAAP EPS (FY2027)",
      "prediction": "BETTER",
      "answer": "guide ~$12.20-12.40 vs. cons $12.07",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP Gross Margin (FY2027)",
      "prediction": "BETTER",
      "answer": "guide 63-64% vs. cons ~62.6% implied",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH - sell-side revises FY2027 EPS up on MatrixCare-adjusted organic growth clarity; short covering adds bid",
  "day5_confidence": "MEDIUM"
}